【结 构 式】 |
【分子编号】19636 【品名】1-(bromomethyl)-3-nitrobenzene 【CA登记号】3958-57-4 |
【 分 子 式 】C7H6BrNO2 【 分 子 量 】216.03418 【元素组成】C 38.92% H 2.8% Br 36.99% N 6.48% O 14.81% |
合成路线1
该中间体在本合成路线中的序号:(VIII)Alkylation of diazepinone (VII) with m-nitrobenzyl bromide (VIII) in the presence of NaH gave the bis-nitrobenzyl derivative (IX). The silylethoxymethyl protecting groups of (IX) were then removed by means of HCl in dioxan to afford diol (X). The nitro groups of (X) were finally reduced by catalytic hydrogenation to the target diamino compound, which was finally converted to the bis-methanesulfonate salt.
【3】 Lam, P.Y.; Eyermann, C.J.; Hodge, C.N.; Jadhav, P.K.; DeLucca, G.V. (DuPont Pharmaceuticals Co.); Cyclic ureas and analogues useful as retroviral protease inhibitors. EP 0607334; EP 0686151; EP 0765873; JP 1995500324; JP 1996509700; US 5610294; WO 9307128; WO 9419329 . |
【1】 Hodge, C.N.; et al.; Improved cyclic urea inhibitors of the HIV-1 protease: Synthesis, potency, resistance profile, human pharmacokinetics and X-ray crystal structure of DMP 450. Chem Biol 1996, 3, 4, 301. |
【2】 Lam, P.Y.S.; et al.; Cyclic HIV protease inhibitors. Synthesis, conformational analysis, P2/P2' structure-activity relationship, and molecular recognition of cyclic ureas. J Med Chem 1996, 39, 18, 3514. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(VII) | 19922 | (4R,5S,6S,7R)-4,7-dibenzyl-5,6-bis[[2-(trimethylsilyl)ethoxy]methoxy]-1,3-diazepan-2-one | C31H50N2O5Si2 | 详情 | 详情 | |
(VIII) | 19636 | 1-(bromomethyl)-3-nitrobenzene | 3958-57-4 | C7H6BrNO2 | 详情 | 详情 |
(IX) | 59259 | (4R,5S,6S,7R)-4,7-dibenzyl-1,3-bis(3-nitrobenzyl)-5,6-bis{[2-(trimethylsilyl)ethoxy]methoxy}-1,3-diazepan-2-one | C45H60N4O9Si2 | 详情 | 详情 | |
(X) | 59260 | (4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis(3-nitrobenzyl)-1,3-diazepan-2-one | C33H32N4O7 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(X)Diol (I) was protected as the bis(methoxymethyl) ether (III) by reaction with methoxymethyl bromide (II) in the presence of diisopropyl ethylamine in DMF, and then, the carbobenzoxy groups of (III) were removed by hydrogenolysis in the presence of Pd/C to afford diamine (IV). Subsequent treatment of (IV) with carbonyl diimidazole (CDI) and pyridine provided the cyclic urea (V). Monoalkylation of (V) with m-iodobenzyl bromide (VI) in the presence KOH and polyethylene glycol in toluene provided the (iodobenzyl)diazepinone (VII). Suzuki coupling of (VII) with the protected pyrazolylboronic acid (VIII) in the presence of Pd(PPh3)4 and K2CO3 afforded the (pyrazolylbenzyl) derivative (IX). Further alkylation of (IX) with m-nitrobenzyl bromide (X) and NaH gave (XI). After deprotection of the methoxymethyl and the (trimethylsilyl)ethoxymethyl groups of (XI) upon treatment with HCl in dioxan-methanol, the title compound was obtained by hydrogenation of the nitro group in the presence of Pd/C.
【1】 Han, Q.; Lam, P.Y.S.; Li, R.; Jadhav, P.K.; Chang, C.-H.; Ru, Y.; Cyclic HIV protease inhibitors: Design and synthesis of orally bioavailable, pyrazole P2/P2' cyclic ureas with improved potency. J Med Chem 1998, 41, 12, 2019. |
【2】 Lam, P.Y.; Eyermann, C.J.; Hodge, C.N.; Jadhav, P.K.; DeLucca, G.V. (DuPont Pharmaceuticals Co.); Cyclic ureas and analogues useful as retroviral protease inhibitors. EP 0607334; EP 0686151; EP 0765873; JP 1995500324; JP 1996509700; US 5610294; WO 9307128; WO 9419329 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 19618 | benzyl (1R,2S,3S,4R)-1-benzyl-4-[[(benzyloxy)carbonyl]amino]-2,3-dihydroxy-5-phenylpentylcarbamate | C34H36N2O6 | 详情 | 详情 | |
(II) | 19619 | bromo(methoxy)methane; bromomethyl methyl ether | 13057-17-5 | C2H5BrO | 详情 | 详情 |
(III) | 19620 | benzyl (1R,2S,3S,4R)-1-benzyl-4-[[(benzyloxy)carbonyl]amino]-2,3-bis(methoxymethoxy)-5-phenylpentylcarbamate | C38H44N2O8 | 详情 | 详情 | |
(IV) | 19621 | (2R,3S,4S,5R)-3,4-bis(methoxymethoxy)-1,6-diphenyl-2,5-hexanediamine; (1R,2S,3S,4R)-4-amino-1-benzyl-2,3-bis(methoxymethoxy)-5-phenylpentylamine | C22H32N2O4 | 详情 | 详情 | |
(V) | 19622 | (4R,5S,6S,7R)-4,7-dibenzyl-5,6-bis(methoxymethoxy)-1,3-diazepan-2-one | C23H30N2O5 | 详情 | 详情 | |
(VI) | 19623 | 1-(bromomethyl)-3-iodobenzene | 49617-83-6 | C7H6BrI | 详情 | 详情 |
(VII) | 19633 | (4R,5S,6S,7R)-4,7-dibenzyl-1-(3-iodobenzyl)-5,6-bis(methoxymethoxy)-1,3-diazepan-2-one | C30H35IN2O5 | 详情 | 详情 | |
(VIII) | 19625 | 1-[[2-(trimethylsilyl)ethoxy]methyl]-1H-pyrazol-5-ylboronic acid | C9H19BN2O3Si | 详情 | 详情 | |
(IX) | 19635 | (4R,5S,6S,7R)-4,7-dibenzyl-5,6-bis(methoxymethoxy)-1-[3-(1-[[2-(trimethylsilyl)ethoxy]methyl]-1H-pyrazol-5-yl)benzyl]-1,3-diazepan-2-one | C39H52N4O6Si | 详情 | 详情 | |
(X) | 19636 | 1-(bromomethyl)-3-nitrobenzene | 3958-57-4 | C7H6BrNO2 | 详情 | 详情 |
(XI) | 19637 | (4R,5S,6S,7R)-4,7-dibenzyl-5,6-bis(methoxymethoxy)-1-(3-nitrobenzyl)-3-[3-(1-[[2-(trimethylsilyl)ethoxy]methyl]-1H-pyrazol-5-yl)benzyl]-1,3-diazepan-2-one | C46H57N5O8Si | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号:(VI)N-Boc-Phenylalanine (I) was treated with isobutyl chloroformate and N-methylmorpholine, and the resulting mixed anhydride (II) was coupled to 2-aminobenzophenone (III) to yield the corresponding amide (IV). After Boc deprotection of (IV) with HCl in EtOAc, the intermediate aminoketone was cyclized with NaOH to the benzodiazepine (V). Alkylation of (V) with 3-nitrobenzyl bromide (VI) in the presence of t-BuOK in THF gave the (nitrobenzyl)benzodiazepine (VII). The nitro group of (VV) was subsequently reduced with SnCl2 in boiling EtOAc to affford (VIII). Then, the resulting amine (VIII) was treated with N,N'-di-Boc-thiourea (IX) in the presence of HgCl2 to provide the diprotected guanidine (X), which was finally deprotected with trifluoroacetic acid in CH2Cl2.
【1】 Dziadulewicz, E.K.; et al.; The design of non-peptide human bradykinin B2 receptor antagonists employing the benzodiazepine peptidomimetic scaffold. Bioorg Med Chem Lett 1999, 9, 3, 463. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 21835 | N-(tert-butoxycarbonyl)phenylalanine | 4530-18-1 | C14H19NO4 | 详情 | 详情 |
(II) | 21836 | N-(Tert-butoxycarbonyl)-DL-phenylalanine isobutoxycarbonyl anhydride | C19H27NO6 | 详情 | 详情 | |
(IV) | 21838 | tert-butyl 2-(2-benzoylanilino)-1-benzyl-2-oxoethylcarbamate | C27H28N2O4 | 详情 | 详情 | |
(V) | 21839 | 3-benzyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one | C22H18N2O | 详情 | 详情 | |
(VI) | 19636 | 1-(bromomethyl)-3-nitrobenzene | 3958-57-4 | C7H6BrNO2 | 详情 | 详情 |
(VII) | 21841 | 3-benzyl-1-(3-nitrobenzyl)-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one | C29H23N3O3 | 详情 | 详情 | |
(VIII) | 21842 | 1-(3-aminobenzyl)-3-benzyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one | C29H25N3O | 详情 | 详情 | |
(IX) | 21843 | tert-butyl [(tert-butoxycarbonyl)amino]carbothioylcarbamate | 145013-05-4 | C11H20N2O4S | 详情 | 详情 |
(X) | 21844 | tert-butyl (Z)-[3-[(3-benzyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-1-yl)methyl]anilino][(tert-butoxycarbonyl)amino]methylidenecarbamate | C40H43N5O5 | 详情 | 详情 |
合成路线4
该中间体在本合成路线中的序号:(IV)Acylation of L-phenylalanine tert-butyl ester (I) with 2,4-dichlorobenzoyl chloride (II) provides the corresponding amide (III). This is then N-alkylated with 3-nitrobenzyl bromide (IV) in the presence of NaH to yield (V). The tert-butyl ester group of (V) is finally cleaved with trifluoroacetic acid to furnish the target carboxylic acid. (1-3)
【1】 Chan, L.; Reddy, J.; Proulx, M.; Das, S.K.; Pereira, O.; Wang, W.; Siddiqui, A.; Yannopoulos, C.G.; Poisson, C.; Turcotte, N.; Drouin, A.; Alaoui-Ismaili, M.H.; Bethell, R.; Hamel, M.; L'Heureux, L.; Bilimoria, D.; Nguyen-Ba, N.; Identification of N,N-disubstituted phenylalanines as a novel class of inhibitors of hepatitis C NS5B polymerase. J Med Chem 2003, 46, 8, 1283. |
【2】 Proulx, M.; Chan, L.; Reddy, T.J.; Das, S.K.; Pereira, O.Z.; Identification of a novel class of inhibitors of hepatitis C NS5B polymerase. 225th ACS Natl Meet (March 23 2003, New Orleans) 2003, Abst MEDI 40. |
【3】 Pereira, O.Z.; Wang, W.; Siddiqui, M.A.; Bedard, J.; Nguyen Ba, N.; Chan, C.K.L.; Das, S.K.; Shuttleworth, S. (Shire BioChem Inc.); Cpds. and methods for the treatment or prevention of flavivirus infections. US 2003229053; WO 02100846 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 60837 | tert-butyl (2S)-2-amino-3-phenylpropanoate | C13H19NO2 | 详情 | 详情 | |
(II) | 35131 | 2,4-dichlorobenzoyl chloride; 2,4-Dichlorophenacylchloride | 89-75-8 | C7H3Cl3O | 详情 | 详情 |
(III) | 64057 | 1,1-dimethylethyl 2-{[(2,4-dichlorophenyl)carbonyl]amino}-3-phenylpropanoate | C20H21Cl2NO3 | 详情 | 详情 | |
(IV) | 19636 | 1-(bromomethyl)-3-nitrobenzene | 3958-57-4 | C7H6BrNO2 | 详情 | 详情 |
(V) | 64058 | 1,1-dimethylethyl 2-{[(2,4-dichlorophenyl)carbonyl][(3-nitrophenyl)methyl]amino}-3-phenylpropanoate | C27H26Cl2N2O5 | 详情 | 详情 |